In summary, GDF-15 can reflect the severity and potential harm of hemodynamic changes and morphological changes in patients with PAH, which provides early and timely prevention and intervention for such patients clinically to improve hemodynamics provide evidence. Here, GDF15 is linked to pulmonary arterial hypertension.